News | September 07, 2008

Study Shows Cost Efficiency of Contrast Echocardiography to Triage ED Patients

September 8, 2008 - Excluding cardiac causes in patients presenting to the emergency department (ED) with chest pain using myocardial contrast echocardiography (MCE) can prevent unnecessary admissions, making it a cost-efficient tool in the evaluation of these patients, according to a study published in the Sept. 15 issue of the American Journal of Cardiology.

Assessment of patients presenting to the ED with suspected cardiac chest pain and a nondiagnostic electrocardiogram (ECG) is lengthy and costly and the study’s authors hypothesized MCE could be used as a more cost-efficient way to detecting those with chest pain that is noncardiac in nature. Accordingly, cost-efficiency was evaluated in 957 patients presenting to the ED with suspected cardiac chest pain, but no ST-segment elevation on the ECG, who underwent MCE. Economic outcome calculations were based on costs estimated from national average Medicare charges adjusted by a cost–charge ratio.

Based on routine clinical criteria, 641 patients (67 percent) were admitted to the hospital, whereas 316 (33 percent) were discharged directly from the ED. The average cost per patient using routine evaluation was $5,000. Patients with normal MCE results (523) had a very low primary event rate (death, acute myocardial infarction) of 0.6 percent within 24 hours after presentation, making it relatively safe to discharge patients directly from the ED with a normal MCE result. Researchers said if MCE had been used for decision making, 523 patients (55 percent) would have been discharged directly from the ED and 434 (45 percent) would have been admitted to the hospital, which would have prevented unnecessary admissions and tests and could have saved an average of $900 per patient.

The study was conducted by the Cardiovascular Division and Department of Emergency Medicine, Oregon Health and Science University, in Portland, OR. The work was supported by a grant from GE Healthcare and grants from the National Institutes of Health and the American Society of Echocardiography.

The study was conducted by doctors Jared J. Wyrick, Saul Kalvaitis, K. John McConnell, Diana Rinkevich, Sanjiv Kaul, and Kevin Wei.

For more information: www.ajconline.org


Related Content

News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
News | Cardiovascular Clinical Studies

Jan. 13, — A new cohort study among 103,642 adults found that current use of cigars was associated with increased risk ...

Home January 14, 2025
Home
News | Cardiovascular Clinical Studies

Nov. 22, 2024 — BridgeBio Pharma, Inc. recently announced that the U.S. Food and Drug Administration (FDA) approved ...

Home November 25, 2024
Home
News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
Subscribe Now